Chevron Left
Voltar para Drug Commercialization

Comentários e feedback de alunos de Drug Commercialization da instituição Universidade da Califórnia, San Diego

1,041 classificações
193 avaliações

Sobre o curso

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success. In addition, the course will discuss post-marketing clinical trials or Phase 4 trials. These are conducted after a new drug has been approved by the regulatory agencies and launched. In these studies, the new drug is prescribed in an everyday healthcare environ­ment using a much larger group of patients. This enables new treat­ment uses for the new drug to be developed, comparisons with other treatments for the same indication to be made, and determination of the clinical effectiveness of the new drug in a wider variety of patient types, and more rare side effects, if any, may be detected . Pre-marketing strategy should be instigated as early as Phase 1 clinical trials to ensure that the market's needs are incorporated into the new drug's overall develop­ment. Later phases when clinical results are presented at international medical conferences the marketing strategy is then refined in order to develop an awareness amongst the medical community who will be prescribing the new drug. In addition to the marketing strategy, pricing strategy and a tactical plan will be developed. Promotional material, and the sales force will be trained so that when the product is approved they can promote the drug to physician, pharmacist and nurses. This course is intended as part 3 of a series: Drug Discovery (, Drug Development ( and Drug Commercialization. We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Melhores avaliações

7 de Jan de 2017

Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.

12 de Mai de 2020

Great contents covering economics, marketing, regulation, IP, academics-industry collaboration, and actual successful biotech startup stories. I highly recommended this course.

Filtrar por:

126 — 150 de 194 Avaliações para o Drug Commercialization

por Dr. S T

17 de Out de 2020

nice experience


11 de Ago de 2020

Love the course

por Prasun N

19 de Jun de 2020

great learning

por �ADITI P

24 de Set de 2020


por Utku U

8 de Abr de 2020


por Sourav M

3 de Nov de 2018

Thank you.


28 de Mai de 2020


por Afroj K

19 de Mai de 2020


por Ngân Đ N T

30 de Nov de 2020

Love it

por Lokesh

19 de Out de 2020


por MRS. S

26 de Ago de 2020



26 de Nov de 2021


por Mintu S T

30 de Set de 2020


por Atocha C S

29 de Nov de 2017


por Md. R Q S

11 de Set de 2020


por Farhan s

24 de Abr de 2021


por 19BBT006-ANASWAR S B B B

13 de Set de 2020


por Uma M K

17 de Jul de 2020


por Mohammad j s

25 de Set de 2017


por Julen D L C

12 de Jan de 2020

The course is pretty good and really interesting, but it is too out-of-date. I think that this course would win a lot if actualized. Sometimes, the content should be more accurate, and in order to make it more useful for (future) workers on the pharmaceutical industry, I think this scheme should be followed in all subjects: present a topic --> main keys to follow when working on this area --> practical examples. Thank you!

por Aedrian A

16 de Jan de 2021

This is a highly insightful course on the reality (both the highs and lows) of the drug commercialization process. Unfortunately, as of this writing, the material is relatively outdated. I hope the instructors provide a necessary massive updating of the contents as soon as possible.

por Olivia P L M

22 de Mai de 2020

Great course that allows me to look somewhat into health economics and other areas such as marketing. It also shows me statistics that can be quite alarming at times. Definitely learnt a lot of interesting terms and built on new knowledge due to this course. Thank you!

por David L

24 de Mai de 2020

Nice introduction to drug commercialization. It's a bit out of date though. The examples were current at the time, but new modalities, i.e. mAbs, cell and gene therapies, have rapidly overtaken small molecules as the "hottest" entities for commercialization.

por Abram S

25 de Jun de 2020

Holistic view of the commercial side of the industry from many different angles. Excellent and varied speakers with interesting cases. The only negative point is the lack of more current data (ending around 2015).

por Anindita R

20 de Set de 2020

Liked the course and learned some interesting information about the pharma and biotech industry. I would have appreciated more updated information, however, those can be found on the internet with some research.